FDA Approved: CYSTADANE — Supplemental Application (Recordati Rare Diseases)

View source ↗

Summary

The FDA approved a supplemental application for CYSTADANE (betaine) submitted by Recordati Rare Diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homocystinuria

Drugs mentioned

• Cystadane (Betaine anhydrous)

Snippet

SUPPL AP for CYSTADANE (BETAINE)